Association	O
between	O
OCT	B:C0920367
-	O
based	O
microangiography	O
perfusion	O
indices	O
and	O
diabetic	O
retinopathy	I:C0011884
severity	O
.	O

Association	O
between	O
OCT	O
-	O
based	O
microangiography	O
perfusion	O
indices	O
and	O
diabetic	B:C0011884
retinopathy	I:C0011884
severity	O
.	O

To	O
evaluate	B:C0220825
the	O
association	O
between	O
retinal	O
capillary	I:C4049512
non-perfusion	I:C4049512
and	O
diabetic	O
retinopathy	I:C0011884
(	O
diabetic	O
retinopathy	I:C0011884
)	O
severity	O
using	O
optical	O
coherence	O
tomography	O
-	O
based	O
microangiography	O
(	O
OMAG	O
)	O
.	O

To	O
evaluate	O
the	O
association	O
between	O
retinal	B:C4049512
capillary	I:C4049512
non-perfusion	I:C4049512
and	O
diabetic	O
retinopathy	I:C0011884
(	O
diabetic	O
retinopathy	I:C0011884
)	O
severity	O
using	O
optical	O
coherence	O
tomography	O
-	O
based	O
microangiography	O
(	O
OMAG	O
)	O
.	O

To	O
evaluate	O
the	O
association	O
between	O
retinal	O
capillary	I:C4049512
non-perfusion	I:C4049512
and	O
diabetic	B:C0011884
retinopathy	I:C0011884
(	O
diabetic	O
retinopathy	I:C0011884
)	O
severity	O
using	O
optical	O
coherence	O
tomography	O
-	O
based	O
microangiography	O
(	O
OMAG	O
)	O
.	O

To	O
evaluate	O
the	O
association	O
between	O
retinal	O
capillary	I:C4049512
non-perfusion	I:C4049512
and	O
diabetic	O
retinopathy	I:C0011884
(	O
diabetic	B:C0011884
retinopathy	I:C0011884
)	O
severity	O
using	O
optical	O
coherence	O
tomography	O
-	O
based	O
microangiography	O
(	O
OMAG	O
)	O
.	O

33	O
patients	O
(	O
51	O
eyes	B:C0015392
)	O
with	O
a	O
history	O
of	I:C0455488
diabetes	I:C0455488
underwent	O
imaging	O
with	O
a	O
68	O
kHz	O
Cirrus	O
-	O
5000	O
spectral	O
domain	I:C3876157
OMAG	I:C3876157
prototype	O
.	O

33	O
patients	O
(	O
51	O
eyes	O
)	O
with	O
a	O
history	B:C0455488
of	I:C0455488
diabetes	I:C0455488
underwent	O
imaging	O
with	O
a	O
68	O
kHz	O
Cirrus	O
-	O
5000	O
spectral	O
domain	I:C3876157
OMAG	I:C3876157
prototype	O
.	O

33	O
patients	O
(	O
51	O
eyes	O
)	O
with	O
a	O
history	O
of	I:C0455488
diabetes	I:C0455488
underwent	O
imaging	B:C0011923
with	O
a	O
68	O
kHz	O
Cirrus	O
-	O
5000	O
spectral	O
domain	I:C3876157
OMAG	I:C3876157
prototype	O
.	O

33	O
patients	O
(	O
51	O
eyes	O
)	O
with	O
a	O
history	O
of	I:C0455488
diabetes	I:C0455488
underwent	O
imaging	O
with	O
a	O
68	O
kHz	O
Cirrus	O
-	O
5000	O
spectral	B:C3876157
domain	I:C3876157
OMAG	I:C3876157
prototype	O
.	O

The	O
perfusion	O
index	O
(	O
PI	O
)	O
was	O
defined	O
as	O
per	O
cent	O
coverage	O
of	O
area	B:C0205146
by	O
retinal	O
vessels	I:C0035330
with	O
flow	O
,	O
measured	O
within	O
a	O
minimum	O
of	O
6.8×6.8	O
mm	O
(	O
2	O
)	O
OMAG	O
scan	O
.	O

The	O
perfusion	O
index	O
(	O
PI	O
)	O
was	O
defined	O
as	O
per	O
cent	O
coverage	O
of	O
area	O
by	O
retinal	B:C0035330
vessels	I:C0035330
with	O
flow	O
,	O
measured	O
within	O
a	O
minimum	O
of	O
6.8×6.8	O
mm	O
(	O
2	O
)	O
OMAG	O
scan	O
.	O

The	O
PI	O
in	O
each	O
ETDRS	B:C3899277
zone	O
was	O
analysed	O
using	O
an	O
automated	O
algorithm	I:C0002045
.	O

The	O
PI	O
in	O
each	O
ETDRS	O
zone	B:C1710706
was	O
analysed	O
using	O
an	O
automated	O
algorithm	I:C0002045
.	O

The	O
PI	O
in	O
each	O
ETDRS	O
zone	O
was	O
analysed	O
using	O
an	O
automated	B:C0002045
algorithm	I:C0002045
.	O

Univariate	O
and	O
multivariate	O
analyses	O
were	O
used	O
to	O
determine	O
the	O
degree	O
of	O
association	O
between	O
PI	O
and	O
diabetic	B:C0011884
retinopathy	I:C0011884
severity	O
.	O

51	O
eyes	B:C0015392
with	O
different	O
diabetic	O
retinopathy	I:C0011884
severities	O
were	O
imaged	O
.	O

51	O
eyes	O
with	O
different	O
diabetic	B:C0011884
retinopathy	I:C0011884
severities	O
were	O
imaged	O
.	O

51	O
eyes	O
with	O
different	O
diabetic	O
retinopathy	I:C0011884
severities	O
were	O
imaged	B:C0011923
.	O

More	O
severe	O
diabetic	B:C0011884
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	O
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	O
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	O
,	O
diabetes	O
type	I:C1320657
and	O
ETDRS	O
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

More	O
severe	O
diabetic	O
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	B:C2603363
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	O
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	O
,	O
diabetes	O
type	I:C1320657
and	O
ETDRS	O
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

More	O
severe	O
diabetic	O
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	O
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	B:C1690532
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	O
,	O
diabetes	O
type	I:C1320657
and	O
ETDRS	O
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

More	O
severe	O
diabetic	O
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	O
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	O
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	B:C0020473
,	O
diabetes	O
type	I:C1320657
and	O
ETDRS	O
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

More	O
severe	O
diabetic	O
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	O
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	O
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	O
,	O
diabetes	B:C1320657
type	I:C1320657
and	O
ETDRS	O
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

More	O
severe	O
diabetic	O
retinopathy	I:C0011884
was	O
significantly	O
associated	O
with	O
lower	O
PI	O
after	O
adjusting	O
for	O
logarithm	O
of	O
the	O
minimum	O
angle	I:C2603363
of	I:C2603363
resolution	I:C2603363
best	O
-	I:C1690532
corrected	I:C1690532
visual	I:C1690532
acuity	I:C1690532
,	O
hyperlipidaemia	O
,	O
diabetes	O
type	I:C1320657
and	O
ETDRS	B:C3899277
ring	O
in	O
a	O
multivariate	O
mixed	O
linear	O
model	O
.	O

Compared	O
with	O
the	O
none	O
-	O
mild	B:C0730276
non-proliferative	I:C0730276
diabetic	I:C0730276
retinopathy	I:C0730276
(	O
non-proliferative	O
diabetic	I:C0730276
retinopathy	I:C0730276
)	O
group	O
,	O
the	O
moderate	O
-	O
severe	O
non-proliferative	O
diabetic	I:C0004606
retinopathy	I:C0004606
group	O
had	O
2.7	O
lower	O
PI	O
(	O
p=0.03	O
)	O
and	O
proliferative	O
DR	I:C0154830
group	O
had	O
4.3	O
lower	O
PI	O
(	O
p=0.003	O
)	O
.	O

Compared	O
with	O
the	O
none	O
-	O
mild	O
non-proliferative	I:C0730276
diabetic	I:C0730276
retinopathy	I:C0730276
(	O
non-proliferative	B:C0730276
diabetic	I:C0730276
retinopathy	I:C0730276
)	O
group	O
,	O
the	O
moderate	O
-	O
severe	O
non-proliferative	O
diabetic	I:C0004606
retinopathy	I:C0004606
group	O
had	O
2.7	O
lower	O
PI	O
(	O
p=0.03	O
)	O
and	O
proliferative	O
DR	I:C0154830
group	O
had	O
4.3	O
lower	O
PI	O
(	O
p=0.003	O
)	O
.	O

Compared	O
with	O
the	O
none	O
-	O
mild	O
non-proliferative	I:C0730276
diabetic	I:C0730276
retinopathy	I:C0730276
(	O
non-proliferative	O
diabetic	I:C0730276
retinopathy	I:C0730276
)	O
group	O
,	O
the	O
moderate	O
-	O
severe	O
non-proliferative	B:C0004606
diabetic	I:C0004606
retinopathy	I:C0004606
group	O
had	O
2.7	O
lower	O
PI	O
(	O
p=0.03	O
)	O
and	O
proliferative	O
DR	I:C0154830
group	O
had	O
4.3	O
lower	O
PI	O
(	O
p=0.003	O
)	O
.	O

Compared	O
with	O
the	O
none	O
-	O
mild	O
non-proliferative	I:C0730276
diabetic	I:C0730276
retinopathy	I:C0730276
(	O
non-proliferative	O
diabetic	I:C0730276
retinopathy	I:C0730276
)	O
group	O
,	O
the	O
moderate	O
-	O
severe	O
non-proliferative	O
diabetic	I:C0004606
retinopathy	I:C0004606
group	O
had	O
2.7	O
lower	O
PI	O
(	O
p=0.03	O
)	O
and	O
proliferative	B:C0154830
DR	I:C0154830
group	O
had	O
4.3	O
lower	O
PI	O
(	O
p=0.003	O
)	O
.	O

All	O
ETDRS	B:C3899277
zones	O
except	O
for	O
the	O
foveal	O
centre	I:C0016622
showed	O
inverse	O
associations	O
between	O
PI	O
and	O
diabetic	O
retinopathy	I:C0011884
severity	O
(	O
p	O
values	O
<	O
0.001	O
to	O
0.862	O
)	O
.	O

All	O
ETDRS	O
zones	B:C1710706
except	O
for	O
the	O
foveal	O
centre	I:C0016622
showed	O
inverse	O
associations	O
between	O
PI	O
and	O
diabetic	O
retinopathy	I:C0011884
severity	O
(	O
p	O
values	O
<	O
0.001	O
to	O
0.862	O
)	O
.	O

All	O
ETDRS	O
zones	O
except	O
for	O
the	O
foveal	B:C0016622
centre	I:C0016622
showed	O
inverse	O
associations	O
between	O
PI	O
and	O
diabetic	O
retinopathy	I:C0011884
severity	O
(	O
p	O
values	O
<	O
0.001	O
to	O
0.862	O
)	O
.	O

All	O
ETDRS	O
zones	O
except	O
for	O
the	O
foveal	O
centre	I:C0016622
showed	O
inverse	O
associations	O
between	O
PI	O
and	O
diabetic	B:C0011884
retinopathy	I:C0011884
severity	O
(	O
p	O
values	O
<	O
0.001	O
to	O
0.862	O
)	O
.	O

A	O
statistically	O
significant	O
inverse	O
association	O
exists	O
between	O
PI	O
and	O
diabetic	B:C0011884
retinopathy	I:C0011884
severity	O
.	O

Our	O
study	O
suggests	O
that	O
PI	O
may	O
become	O
a	O
useful	O
biomarker	B:C0005516
in	O
evaluating	O
and	O
following	O
the	O
progression	O
of	O
diabetic	O
retinopathy	I:C0011884
.	O

Our	O
study	O
suggests	O
that	O
PI	O
may	O
become	O
a	O
useful	O
biomarker	O
in	O
evaluating	B:C0184781
and	O
following	O
the	O
progression	O
of	O
diabetic	O
retinopathy	I:C0011884
.	O

Our	O
study	O
suggests	O
that	O
PI	O
may	O
become	O
a	O
useful	O
biomarker	O
in	O
evaluating	O
and	O
following	O
the	O
progression	B:C0242656
of	O
diabetic	O
retinopathy	I:C0011884
.	O

Our	O
study	O
suggests	O
that	O
PI	O
may	O
become	O
a	O
useful	O
biomarker	O
in	O
evaluating	O
and	O
following	O
the	O
progression	O
of	O
diabetic	B:C0011884
retinopathy	I:C0011884
.	O

